| Application no. and date | 15791391.4 (espacenet) (Federated) (European Patent Register), 20151009 | | Patent/reg. no. and date | DK/EP 3359139, 20230607 | | Publication date | 20180815 | | Priority no. and date | | | EP pub. no. and date |
EP 3359139 20180815 | | Effective date | | | Applicant/owner | Bayer HealthCare LLC, 100 Bayer Boulevard
PO Box 915
Whippany, NJ 07981, US | | Applicant ref. no. | | | Inventor | SIRIHORACHAI, Rachan, Bayer Healthcare LLC
100 Bayer Blvd.
P.O. Box 915
Whippany, NJ 07981, US,
ROSAR, Paul, Bayer Healthcare LLC
100 Bayer Blvd.
P.O. Box 915
Whippany, NJ 07981, US | | Representative | | | Opponent | | | IPC Class | A61K 31/192 (2006.01) , A61K 9/24 (2006.01) | | Title | MODIFIED RELEASE FORMULATION OF NAPROXEN SODIUM | | Int. application no. | US2015054873 | | Int. publication no. | WO2017062027 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
